L'ospedale San Gerardo di Monza è il principale presidio sanitario della ASST Monza, prossima a diventare Fondazione IRCCS San Gerardo dei Tintori, nell'ottica della conversione dell'ospedale in Istituto ...

During the past decade, Ospedale San Gerardo conducted 128 clinical trials. In the 10-year time frame, 128 clinical trials started and 38 clinical trials were completed, i.e. on average, 29.7% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 22 clinical trials were completed. i.e. 33.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Gerardo" #1 sponsor was "University of Milano Bicocca" with 16 trials, followed by "Hoffmann-La Roche" with 11 trials sponsored, "Boehringer Ingelheim" with 9 trials sponsored, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 9 trials sponsored and "Janssen Research & Development, LLC" with 9 trials sponsored. Other sponsors include 164 different institutions and companies that sponsored additional 97 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Gerardo" #1 collaborator was "Azienda Ospedaliera San Gerardo di Monza" with 5 trials as a collaborator, "San Gerardo Hospital" with 5 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator, "Agenzia Italiana del Farmaco" with 3 trials as a collaborator and "IRCCS Policlinico S. Matteo" with 3 trials as a collaborator. Other collaborators include 211 different institutions and companies that were collaborators in the rest 194 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Gerardo" are "Idiopathic Pulmonary Fibrosis" (7 trials), "Breast Cancer" (6 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Lung Cancer" (5 trials) and "Ovarian Cancer" (5 trials). Many other conditions were trialed in "Ospedale San Gerardo" in a lesser frequency.

Most popular intervention types in "Ospedale San Gerardo" are "Drug" (141 trials), "Procedure" (28 trials), "Other" (18 trials), "Biological" (16 trials) and "Device" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Carboplatin" (9 trials), "Gemcitabine" (7 trials), "placebo" (6 trials) and "Nintedanib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Gerardo" are 198 trials for "All" genders, 22 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale San Gerardo". undefined are not yet recruiting, 37 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 114 completed trials in Ospedale San Gerardo, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Gerardo, 9 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 18 trials that are defined as “Not Applicable".